iShares Genomics Immunology and Healthcare ETF
IDNA
11 hedge funds and large institutions have $14.8M invested in iShares Genomics Immunology and Healthcare ETF in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
120% more funds holding
Funds holding: 5 → 11 (+6)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
34% less capital invested
Capital invested by funds: $22.3M → $14.8M (-$7.51M)
47.92% less ownership
Funds ownership: 82.52% → 34.59% (-48%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$1.72M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.21M |
| 3 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$1.14M |
| 4 |
AIC
Archer Investment Corporation
Carmel,
Indiana
|
+$256K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$28.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$16.6M |
| 2 |
RIA
Realta Investment Advisors
Wilmington,
Delaware
|
-$12K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9K |
IDNA Hedge Fund Activity: Q1 2020 in Review
11 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q1 2020, worth a combined $14.8M — down 34% from $22.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IDNA positions and 2 closed out — a net gain of 6 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Sowell Financial Services, opening a new position worth an estimated $1.72M. The largest seller was BlackRock, cutting an estimated $16.6M.
- 11 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q1 2020, up from 5 in Q4 2019.
- Funds reported $14.8M of iShares Genomics Immunology and Healthcare ETF stock for Q1 2020, down 34% quarter-over-quarter.
- 8 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q1 2020 and 2 closed out, a net change of +6 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q1 2020 was Sowell Financial Services, an estimated $1.72M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q1 2020 was BlackRock, an estimated $16.6M sold.
Based on aggregated 13F filings for Q1 2020.